Sept 16 (Reuters) - VALBIOTIS SA ALVAL.PA :
* VALBIOTIS PRESENTS POSITIVE RESULTS FROM A STUDY ON
TOTUM-63,
ACTIVE SUBSTANCE OF VALEDIA®, CONDUCTED BY THE CARMEN LABORATORY
IN LYON, AT THE ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR
THE STUDY OF DIABETES (EASD)
* DATA DEMONSTRATES CAPACITY OF TOTUM-63 TO SIGNIFICANTLY
CORRECT
SECRETION OF THREE HORMONES
* PRECLINICAL STUDY CONFIRMS MAJOR EFFECTS OF ACTIVE
SUBSTANCE
TOTUM-63 ON WEIGHT AND GLUCOSE METABOLISM
Source text for Eikon: ID:nBw1mGfnka
Further company coverage: ALVAL.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))